297 related articles for article (PubMed ID: 32973812)
1. Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary.
Schwich E; Hò GT; LeMaoult J; Bade-Döding C; Carosella ED; Horn PA; Rebmann V
Front Immunol; 2020; 11():2046. PubMed ID: 32973812
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
3. CD8
Dumont C; Jacquier A; Verine J; Noel F; Goujon A; Wu CL; Hung TM; Desgrandchamps F; Culine S; Carosella ED; Rouas-Freiss N; LeMaoult J
Cancer Immunol Res; 2019 Oct; 7(10):1619-1632. PubMed ID: 31451484
[TBL] [Abstract][Full Text] [Related]
4. Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
Rohn H; Schramm S; Pansikaki K; Jansen S; Hendriks C; Platte M; Konik MJ; Dolff S; Wilde B; Kordelas L; Trilling M; Krawczyk A; Horn PA; Witzke O; Rebmann V
Hum Immunol; 2023 Aug; 84(8):393-400. PubMed ID: 36925435
[TBL] [Abstract][Full Text] [Related]
5. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of HLA-G and ILT-2 receptor in human tuberculosis: Localized versus disseminated disease.
Saurabh A; Thakral D; Mourya MK; Singh A; Mohan A; Bhatnagar AK; Mitra DK; Kanga U
Hum Immunol; 2016 Sep; 77(9):746-53. PubMed ID: 26776460
[TBL] [Abstract][Full Text] [Related]
7. HLA-G/LILRBs: A Cancer Immunotherapy Challenge.
Carosella ED; Gregori S; Tronik-Le Roux D
Trends Cancer; 2021 May; 7(5):389-392. PubMed ID: 33563576
[TBL] [Abstract][Full Text] [Related]
8. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
9. Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.
Hoffmann O; Wormland S; Bittner AK; Hölzenbein J; Schwich E; Schramm S; Rohn H; Horn PA; Kimmig R; Kasimir-Bauer S; Rebmann V
Front Immunol; 2023; 14():1188030. PubMed ID: 37283737
[TBL] [Abstract][Full Text] [Related]
10. Human leukocyte antigen-G and regulatory T cells during specific immunotherapy for pollen allergy.
Sørensen AE; Johnsen CR; Dalgaard LT; Würtzen PA; Kristensen B; Larsen MH; Ullum H; Søes-Petersen U; Hviid TV
Int Arch Allergy Immunol; 2013; 162(3):237-52. PubMed ID: 24022071
[TBL] [Abstract][Full Text] [Related]
11. Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells.
Rohn H; Lang C; Schramm S; Heinemann FM; Trilling M; Gäckler A; Witzke O; Horn PA; Rebmann V
J Immunol Res; 2022; 2022():4829227. PubMed ID: 35600048
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.
Contini P; Negrini S; Murdaca G; Borro M; Puppo F
Clin Exp Immunol; 2018 Aug; 193(2):152-159. PubMed ID: 29660112
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
[TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles from regenerative human cardiac cells act as potent immune modulators by priming monocytes.
Beez CM; Haag M; Klein O; Van Linthout S; Sittinger M; Seifert M
J Nanobiotechnology; 2019 May; 17(1):72. PubMed ID: 31133024
[TBL] [Abstract][Full Text] [Related]
17. HLA-G and HLA-E in patients with juvenile idiopathic arthritis.
Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F
Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170
[TBL] [Abstract][Full Text] [Related]
18. First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Anna F; Bole-Richard E; LeMaoult J; Escande M; Lecomte M; Certoux JM; Souque P; Garnache F; Adotevi O; Langlade-Demoyen P; Loustau M; Caumartin J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737343
[TBL] [Abstract][Full Text] [Related]
19. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
Puppo F; Contini P; Ghio M; Indiveri F
ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting HLA-G restores IFN-γ and TNF-α producing T cell in pleural Tuberculosis.
Saurabh A; Chakraborty S; Kumar P; Mohan A; Bhatnagar AK; Rishi N; Mitra DK
Tuberculosis (Edinb); 2018 Mar; 109():69-79. PubMed ID: 29559123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
